East Coast medical cannabis firm Rua Bioscience has filed documents for a 50c a share initial public offering (IPO) on the NZX, valuing the budding company at $70 million post offer.
Founded in 2016 and formerly known as Hikurangi Cannabis Company, Rua hopes to raise $20m through the float,
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
